Davita - Leitchfield Dialysis is a medicare approved dialysis facility center in Leitchfield, Kentucky and it has 10 dialysis stations. It is located in Grayson county at 912 Wallace Ave., Suite 106, Leitchfield, KY, 42754. You can reach out to the office of Davita - Leitchfield Dialysis at (270) 230-0153. This dialysis clinic is managed and/or owned by Davita. Davita - Leitchfield Dialysis has the following ownership type - Profit. It was first certified by medicare in May, 2005. The medicare id for this facility is 182574 and it accepts patients under medicare ESRD program.
| Name | Davita - Leitchfield Dialysis |
|---|---|
| Location | 912 Wallace Ave., Suite 106, Leitchfield, Kentucky |
| No. of Dialysis Stations | 10 |
| Medicare ID | 182574 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 912 Wallace Ave., Suite 106, Leitchfield, Kentucky, 42754 | |
| (270) 230-0153 | |
News Archive
A coalition of U.S. health care businesses, including Minnesota-based UnitedHealth Group and Medtronic, proposes to rebuild America's battered economy by selling the country's "health ecosystem" internationally.
The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
Michigan's state unemployment insurance agency has sent letters to 500,000 residents warning them that their benefits could expire starting in March if Congress fails to act on extending jobless benefits including a federal subsidy for COBRA health insurance, The Detroit News reports.
› Verified 1 days ago
| NPI Number | 1790740652 |
| Organization Name | Leitchfield Dialysis |
| Doing Business As | Renal Life Link Inc |
| Address | 912 Wallace Ave Leitchfield, Kentucky, 42754 |
| Phone Number | (270) 230-0163 |
News Archive
A coalition of U.S. health care businesses, including Minnesota-based UnitedHealth Group and Medtronic, proposes to rebuild America's battered economy by selling the country's "health ecosystem" internationally.
The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
Michigan's state unemployment insurance agency has sent letters to 500,000 residents warning them that their benefits could expire starting in March if Congress fails to act on extending jobless benefits including a federal subsidy for COBRA health insurance, The Detroit News reports.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 22 |
News Archive
A coalition of U.S. health care businesses, including Minnesota-based UnitedHealth Group and Medtronic, proposes to rebuild America's battered economy by selling the country's "health ecosystem" internationally.
The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
Michigan's state unemployment insurance agency has sent letters to 500,000 residents warning them that their benefits could expire starting in March if Congress fails to act on extending jobless benefits including a federal subsidy for COBRA health insurance, The Detroit News reports.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 44 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 385 |
| Percentage of adult patients getting regular hemodialysis at the center | 95 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
A coalition of U.S. health care businesses, including Minnesota-based UnitedHealth Group and Medtronic, proposes to rebuild America's battered economy by selling the country's "health ecosystem" internationally.
The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
Michigan's state unemployment insurance agency has sent letters to 500,000 residents warning them that their benefits could expire starting in March if Congress fails to act on extending jobless benefits including a federal subsidy for COBRA health insurance, The Detroit News reports.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Leitchfield Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 45 |
| Hypercalcemia patient months | 397 |
| Patients with Serumphosphor | 46 |
| Patients with Serumphosphor less than 3.5 mg/dL | 4 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 22 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 33 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 20 |
News Archive
A coalition of U.S. health care businesses, including Minnesota-based UnitedHealth Group and Medtronic, proposes to rebuild America's battered economy by selling the country's "health ecosystem" internationally.
The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
Michigan's state unemployment insurance agency has sent letters to 500,000 residents warning them that their benefits could expire starting in March if Congress fails to act on extending jobless benefits including a federal subsidy for COBRA health insurance, The Detroit News reports.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 39 |
| Patient months included in arterial venous fistula and catheter summaries | 297 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 83 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 3 |
News Archive
A coalition of U.S. health care businesses, including Minnesota-based UnitedHealth Group and Medtronic, proposes to rebuild America's battered economy by selling the country's "health ecosystem" internationally.
The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
Michigan's state unemployment insurance agency has sent letters to 500,000 residents warning them that their benefits could expire starting in March if Congress fails to act on extending jobless benefits including a federal subsidy for COBRA health insurance, The Detroit News reports.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 37 |
| Hospitalization Rate in facility | 153.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 310 |
| Hospitalization Rate: Lower Confidence Limit | 79.8 |
News Archive
A coalition of U.S. health care businesses, including Minnesota-based UnitedHealth Group and Medtronic, proposes to rebuild America's battered economy by selling the country's "health ecosystem" internationally.
The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
Michigan's state unemployment insurance agency has sent letters to 500,000 residents warning them that their benefits could expire starting in March if Congress fails to act on extending jobless benefits including a federal subsidy for COBRA health insurance, The Detroit News reports.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - Leitchfield Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 24.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 39.2 |
| Readmission Rate: Lower Confidence Limit | 12.5 |
News Archive
A coalition of U.S. health care businesses, including Minnesota-based UnitedHealth Group and Medtronic, proposes to rebuild America's battered economy by selling the country's "health ecosystem" internationally.
The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
Michigan's state unemployment insurance agency has sent letters to 500,000 residents warning them that their benefits could expire starting in March if Congress fails to act on extending jobless benefits including a federal subsidy for COBRA health insurance, The Detroit News reports.
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Leitchfield Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .97 (As Expected) |
| SIR: Upper Confidence Limit | 3.19 |
| SIR: Lower Confidence Limit | .16 |
News Archive
A coalition of U.S. health care businesses, including Minnesota-based UnitedHealth Group and Medtronic, proposes to rebuild America's battered economy by selling the country's "health ecosystem" internationally.
The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
Michigan's state unemployment insurance agency has sent letters to 500,000 residents warning them that their benefits could expire starting in March if Congress fails to act on extending jobless benefits including a federal subsidy for COBRA health insurance, The Detroit News reports.
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Leitchfield Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 32 |
| Transfusion Rate in facility | 18.6 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 108.7 |
| Transfusion Rate: Lower Confidence Limit | 3.9 |
News Archive
A coalition of U.S. health care businesses, including Minnesota-based UnitedHealth Group and Medtronic, proposes to rebuild America's battered economy by selling the country's "health ecosystem" internationally.
The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
Michigan's state unemployment insurance agency has sent letters to 500,000 residents warning them that their benefits could expire starting in March if Congress fails to act on extending jobless benefits including a federal subsidy for COBRA health insurance, The Detroit News reports.
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita - Leitchfield Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 142 |
| Mortality Rate in facility | 14.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 22.3 |
| Mortality Rate: Lower Confidence Limit | 9.4 |
News Archive
A coalition of U.S. health care businesses, including Minnesota-based UnitedHealth Group and Medtronic, proposes to rebuild America's battered economy by selling the country's "health ecosystem" internationally.
The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
Michigan's state unemployment insurance agency has sent letters to 500,000 residents warning them that their benefits could expire starting in March if Congress fails to act on extending jobless benefits including a federal subsidy for COBRA health insurance, The Detroit News reports.
› Verified 1 days ago
Davita - Leitchfield Dialysis Location: 912 Wallace Ave., Suite 106, Leitchfield, Kentucky, 42754 Phone: (270) 230-0153 |
News Archive
A coalition of U.S. health care businesses, including Minnesota-based UnitedHealth Group and Medtronic, proposes to rebuild America's battered economy by selling the country's "health ecosystem" internationally.
The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
Michigan's state unemployment insurance agency has sent letters to 500,000 residents warning them that their benefits could expire starting in March if Congress fails to act on extending jobless benefits including a federal subsidy for COBRA health insurance, The Detroit News reports.
› Verified 1 days ago